Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Asthma | Treatment Algorithms: Claims Data Analysis | Adult Asthma | US | 2019
Pharmacotherapy for adult asthma has two main goals: address underlying airway inflammation and promote bronchodilation. Two types of therapy are used to achieve these goals—maintenance therapy (…
Systemic Lupus Erythematosus | Treatment Algorithms | Claims Data Analysis | US | 2019
Hydroxychloroquine, corticosteroids, and conventional immunosuppressants are the mainstay of treatment for systemic lupus erythematosus (SLE), a chronic, complex autoimmune disease affecting…
Atopic Dermatitis/Atopic Eczema | Treatment Algorithms: Claims Data Analysis | Adult | US | 2019
MARKET OUTLOOK Atopic dermatitis (AD) is a chronic inflammatory skin disease marked by pruritus, eczema, and, in some cases, disrupted sleep and poor quality of life. Topical agents (e.g.,…
Ulcerative Colitis | Treatment Algorithms: Claims Data Analysis | Pediatric | US | 2019
MARKET OUTLOOK Conventional therapies (5-ASAs, corticosteroids) are typically used to treat mild to moderate pediatric ulcerative colitis (UC), whereas tumor necrosis factor-alpha (TNF-α)…
Psoriatic Arthritis | Emerging Therapies | Xeljanz (tofacitinib) | US | Wave 3 | 2019
Xeljanz is the first-in-class JAK inhibitor approved for psoriatic arthritis (PsA) and the only other oral targeted therapy besides Celgene’s PDE-4 inhibitor, Otezla, approved for this indication…
Allergic Rhinitis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Allergic Rhinitis (US)
Allergic rhinitis is a chronic immunoglobulin E-mediated respiratory response to environmental allergens. It is typically treated with intranasal corticosteroids, followed by antihistamines, mast…
